Experts discuss how checkpoint inhibitors, cystectomy, and other treatment modalities fit into the current landscape for non–muscle-invasive bladder cancer.
Suzanne B. Merrill, MD, FACS
Advertisement
Articles by Suzanne B. Merrill, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
VT-EBV-N Yields Durable Disease-Free Survival in Pretreated ENKTL
2
Tisa-Cel Yields Enduring Remissions in Younger High-Risk B-ALL Population
3
Anbenitamab Regimen Meets Phase 3 End Points in HER2+ Breast Cancer
4
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
5